FDA approved the design of registration trials for the neuroprotector Privosegtor for the treatment of optic neuritis. Learn how the drug can change neuro-ophthalmology and what prospects the SPA agreement opens.
Analysis of the regulatory paradox: why the FDA rejected it three times, while Europe approved it. Learn how the Lytenava decision will change the $16 billion AMD market.
FDA accepted Outlook Therapeutics' appeal and will approve LYTENAVA — a standardized bevacizumab for neovascular AMD. Analysis of consequences for the anti-VEGF market, pricing, and patients. Read more.
Interim data from phase 1/2 gene therapy AAVB-081 for Usher syndrome 1B: safety, efficacy, and prognosis. Learn about the dual AAV vector and treatment prospects.
From the web
Ophthalmology - Wikipedia
https://en.wikipedia.org/wiki/Ophthalmology
Ophthalmology (/ ˌɒfθælˈmɒlədʒi /, OFF-thal-MOL-ə-jee) [1] is the branch of medicine that deals with the diagnosis, treatment, and …
Home Page: Ophthalmology
https://www.aaojournal.org/
The mission of the American Academy of Ophthalmology is to protect sight and empower lives by serving as an advocate for patients …
Vitreum Eye Clinic – Ophthalmology Services
https://vitreum.ro/en/
Eye examinations, surgery, treatments and optical services at Vitreum eye clinics, ophthalmology offices and optical stores.